Wave Life Sciences (WVE) Revenue Growth (5y) (2020 - 2025)
Wave Life Sciences (WVE) Revenue Growth (5y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - |
| 4 | BeOne Medicines | 472.11 Bn | 467.32 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.89 Bn | 114.65 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - |
| 8 | Argenx Se | 55.82 Bn | 50.63 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.49 Bn | 37.49 Bn | - |
| 10 | Wave Life Sciences | 1.20 Bn | 652.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 23.51% |
| Mar 31, 2025 | 17.13% |
| Jun 30, 2024 | 20.89% |
| Mar 31, 2024 | 32.88% |
| Dec 31, 2023 | 51.67% |
| Sep 30, 2023 | 61.40% |
| Jun 30, 2023 | 35.28% |
| Mar 31, 2023 | 55.50% |
| Dec 31, 2022 | 2.45% |
| Sep 30, 2022 | -26.35% |
| Jun 30, 2022 | -19.32% |
| Mar 31, 2022 | 35.51% |
| Dec 31, 2021 | 21.16% |
| Sep 30, 2021 | 147.52% |
| Jun 30, 2021 | 46.10% |
| Jun 30, 2020 | 88.85% |
| Mar 31, 2020 | 175.96% |